ATE234603T1 - Osmotisches verabreichungsystem mit raumsparenden kolben - Google Patents

Osmotisches verabreichungsystem mit raumsparenden kolben

Info

Publication number: ATE234603T1
Authority: AT; Austria
Prior art keywords: piston; space; osmotic; capsule; pistons
Prior art date: 1998-12-31

Application number

AT99967575T

Other languages

English (en)

Inventor

Bonnie J Eckenhoff

Felix Theeuwes

James B Di Eckenhoff

Original Assignee

Alza Corp

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1998-12-31

Filing date

1999-12-21

Publication date

2003-04-15

1999-12-21 Application filed by Alza Corp filed Critical Alza Corp

2003-04-15 Application granted granted Critical

2003-04-15 Publication of ATE234603T1 publication Critical patent/ATE234603T1/de

Links

230000003204 osmotic effect Effects 0.000 title abstract 2
239000002775 capsule Substances 0.000 abstract 3
239000002357 osmotic agent Substances 0.000 abstract 3
108090000765 processed proteins & peptides Proteins 0.000 abstract 2
102000004169 proteins and genes Human genes 0.000 abstract 2
108090000623 proteins and genes Proteins 0.000 abstract 2
230000009286 beneficial effect Effects 0.000 abstract 1
239000003795 chemical substances by application Substances 0.000 abstract 1
239000007788 liquid Substances 0.000 abstract 1
229920001184 polypeptide Polymers 0.000 abstract 1
102000004196 processed proteins & peptides Human genes 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
- A61K9/0004—Osmotic delivery systems; Sustained release driven by osmosis, thermal energy or gas

Landscapes

Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Epidemiology (AREA)
Bioinformatics & Cheminformatics (AREA)
Life Sciences & Earth Sciences (AREA)
General Health & Medical Sciences (AREA)
Engineering & Computer Science (AREA)
Veterinary Medicine (AREA)
Medicinal Preparation (AREA)
Infusion, Injection, And Reservoir Apparatuses (AREA)
Separation Using Semi-Permeable Membranes (AREA)
External Artificial Organs (AREA)
Media Introduction/Drainage Providing Device (AREA)

AT99967575T 1998-12-31 1999-12-21 Osmotisches verabreichungsystem mit raumsparenden kolben ATE234603T1 (de)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US11454898P	1998-12-31	1998-12-31
PCT/US1999/030783 WO2000040218A2 (en)	1998-12-31	1999-12-21	Osmotic delivery system having space efficient piston

Publications (1)

Publication Number	Publication Date
ATE234603T1 true ATE234603T1 (de)	2003-04-15

Family

ID=22355938

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT99967575T ATE234603T1 (de)	1998-12-31	1999-12-21	Osmotisches verabreichungsystem mit raumsparenden kolben

Country Status (13)

Country	Link
US (5)	US6544252B1 (de)
EP (1)	EP1140014B1 (de)
JP (2)	JP4383674B2 (de)
AT (1)	ATE234603T1 (de)
AU (1)	AU771132B2 (de)
CA (1)	CA2356860C (de)
DE (1)	DE69906132T2 (de)
DK (1)	DK1140014T3 (de)
ES (1)	ES2196918T3 (de)
HK (1)	HK1040916B (de)
NZ (1)	NZ512671A (de)
PT (1)	PT1140014E (de)
WO (1)	WO2000040218A2 (de)

Families Citing this family (58)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6440457B1 (en) *	1993-05-27	2002-08-27	Alza Corporation	Method of administering antidepressant dosage form
MY125870A (en) *	1997-07-25	2006-08-30	Alza Corp	Osmotic delivery system flow modulator apparatus and method
ATE234603T1 (de) *	1998-12-31	2003-04-15	Alza Corp	Osmotisches verabreichungsystem mit raumsparenden kolben
US7258869B1 (en) *	1999-02-08	2007-08-21	Alza Corporation	Stable non-aqueous single phase viscous vehicles and formulations utilizing such vehicle
US7919109B2 (en)	1999-02-08	2011-04-05	Intarcia Therapeutics, Inc.	Stable non-aqueous single phase viscous vehicles and formulations utilizing such vehicles
DE60023361T2 (de) *	1999-12-21	2006-04-27	Alza Corp., Mountain View	Ventil für osmotische vorrichtungen
US7163688B2 (en) *	2001-06-22	2007-01-16	Alza Corporation	Osmotic implant with membrane and membrane retention means
CN1668279A (zh) *	2002-06-17	2005-09-14	阿尔萨公司	具有包含分散在液体载体中的渗透物质的早期零级推动力动力系统的渗透递送体系
US7731947B2 (en) *	2003-11-17	2010-06-08	Intarcia Therapeutics, Inc.	Composition and dosage form comprising an interferon particle formulation and suspending vehicle
CA2508124A1 (en) *	2002-12-19	2004-07-08	Alza Corporation	Stable, non-aqueous, single-phase gels and formulations thereof for delivery from an implantable device
CA2520610A1 (en) *	2003-03-31	2004-10-21	Alza Corporation	Osmotic pump with means for dissipating internal pressure
AR043810A1 (es) *	2003-03-31	2005-08-17	Alza Corp	Sistema osmotico de administracion y metodo para disminuir los tiempos de llegada al regimen de funcionamiento en los sistemas osmoticos de administracion
US8257963B2 (en)	2007-06-01	2012-09-04	Depuy Mitek, Inc.	Chondrocyte container and method of use
JP2007526792A (ja) *	2003-11-06	2007-09-20	アルザ・コーポレーシヨン	移植可能な浸透ポンプと一緒の使用のためのモジュール型の吸入速度低下器
JP2007517911A (ja) *	2004-01-13	2007-07-05	バソジェニックスファーマシューティカルズ，インコーポレイテッド	心臓血管の適応症および腎臓の適応症に対してｃｇｒｐを使用する方法
WO2005067890A2 (en) *	2004-01-13	2005-07-28	Vasogenix Pharmaceuticals, Inc.	Controlled release cgrp delivery composition for cardiovascular and renal indications
CA2552758A1 (en) *	2004-01-13	2005-08-04	Vasogenix Pharmaceuticals, Inc.	Methods for treating acute myocardial infarction by administering calcitonin gene related peptide and compositions containing the same
US20050266087A1 (en) *	2004-05-25	2005-12-01	Gunjan Junnarkar	Formulations having increased stability during transition from hydrophobic vehicle to hydrophilic medium
US7655254B2 (en) *	2005-02-03	2010-02-02	Intarcia Therapeutics, Inc.	Implantable device for continuous delivery of interferon
WO2006083761A2 (en)	2005-02-03	2006-08-10	Alza Corporation	Solvent/polymer solutions as suspension vehicles
US11246913B2 (en)	2005-02-03	2022-02-15	Intarcia Therapeutics, Inc.	Suspension formulation comprising an insulinotropic peptide
US7959938B2 (en) *	2005-03-15	2011-06-14	Intarcia Therapeutics, Inc.	Polyoxaester suspending vehicles for use with implantable delivery systems
US20070025869A1 (en) *	2005-07-15	2007-02-01	Gordon John H	Fluid Delivery Device
US20070163968A1 (en) *	2006-01-17	2007-07-19	Johnsondiversey, Inc.	Method and apparatus for providing treatment chemicals to process water systems
WO2007140416A2 (en)	2006-05-30	2007-12-06	Intarcia Therapeutics, Inc.	Two-piece, internal-channel osmotic delivery system flow modulator
US7583999B2 (en)	2006-07-31	2009-09-01	Cranial Medical Systems, Inc.	Multi-channel connector for brain stimulation system
US8321025B2 (en) *	2006-07-31	2012-11-27	Cranial Medical Systems, Inc.	Lead and methods for brain monitoring and modulation
PT2359808E (pt)	2006-08-09	2013-08-28	Intarcia Therapeutics Inc	Sistemas de entrega osmótica e montagens de pistão
US7538652B2 (en) *	2006-08-29	2009-05-26	International Business Machines Corporation	Electrical component tuned by conductive layer deletion
US20080147186A1 (en) *	2006-12-14	2008-06-19	Joshi Ashok V	Electrochemical Implant For Delivering Beneficial Agents
ES2402172T3 (es)	2007-04-23	2013-04-29	Intarcia Therapeutics, Inc	Formulación en suspensión de péptidos insulinotrópicos y usos de los mismos
WO2009102467A2 (en)	2008-02-13	2009-08-20	Intarcia Therapeutics, Inc.	Devices, formulations, and methods for delivery of multiple beneficial agents
CN102281865B (zh) *	2008-10-15	2017-04-05	精达制药公司	高浓缩药物颗粒、制剂、混悬剂及其应用
EP3735944A1 (de) *	2009-09-28	2020-11-11	Intarcia Therapeutics, Inc.	Schnelle initiierung und/oder beendigung der verabreichung substantiell stabiler arzneimittel
JP2011104346A (ja) *	2009-10-22	2011-06-02	Neocel:Kk	人工透析用具
JP5864429B2 (ja)	2009-11-09	2016-02-17	スポットライトテクノロジーパートナーズエルエルシーＳｐｏｔｌｉｇｈｔＴｅｃｈｎｏｌｏｇｙＰａｒｔｎｅｒｓＬｌｃ	架橋ヒドロゲル組成物、ヒドロゲル組成物の形成方法、及びキット
JP2013509963A (ja)	2009-11-09	2013-03-21	スポットライトテクノロジーパートナーズエルエルシー	断片化ヒドロゲル
JP2013540464A (ja)	2010-08-30	2013-11-07	サイナシスコーポレーション	副鼻腔開口部を拡張するため、および副鼻腔炎を治療するためのデバイスおよび方法
US8583237B2 (en)	2010-09-13	2013-11-12	Cranial Medical Systems, Inc.	Devices and methods for tissue modulation and monitoring
US20120208755A1 (en)	2011-02-16	2012-08-16	Intarcia Therapeutics, Inc.	Compositions, Devices and Methods of Use Thereof for the Treatment of Cancers
EP2819740A4 (de)	2012-02-29	2015-11-25	Sinusys Corp	Vorrichtungen und verfahren zur dilatation einer paranasalen sinusöffnung und zur behandlung von sinusitis
US9687263B2 (en)	2013-05-30	2017-06-27	SinuSys Corporation	Devices and methods for inserting a sinus dilator
US9757330B2 (en)	2013-10-18	2017-09-12	Industrial Technology Research Institute	Recipe for in-situ gel, and implant, drug delivery system formed thereby
US9889085B1 (en)	2014-09-30	2018-02-13	Intarcia Therapeutics, Inc.	Therapeutic methods for the treatment of diabetes and related conditions for patients with high baseline HbA1c
KR102650751B1 (ko)	2015-06-03	2024-03-22	인타르시아 세라퓨틱스 인코포레이티드	임플란트 배치 및 제거 시스템들
PL3370705T3 (pl)	2015-11-05	2022-08-01	The General Hospital Corporation	Dooponowe dostarczanie sekwencji kwasów nukleinowych do kodowania abcd1 w leczeniu adrenomieloneuropatii
CN109310743A (zh)	2016-05-16	2019-02-05	因塔西亚制药公司	胰高血糖素受体选择性多肽及其使用方法
USD840030S1 (en)	2016-06-02	2019-02-05	Intarcia Therapeutics, Inc.	Implant placement guide
USD860451S1 (en)	2016-06-02	2019-09-17	Intarcia Therapeutics, Inc.	Implant removal tool
US10406336B2 (en)	2016-08-03	2019-09-10	Neil S. Davey	Adjustable rate drug delivery implantable device
EP4635569A3 (de)	2016-10-20	2025-12-31	Peptron, Inc.	Verfahren zur abgabe eines neuroprotektiven polypeptids an das zentrale nervensystem
AU2018206539A1 (en)	2017-01-03	2019-07-18	Intarcia Therapeutics, Inc.	Methods comprising continuous administration of a GLP-1 receptor agonist and co-administration of a drug
WO2018165462A1 (en)	2017-03-08	2018-09-13	Intarcia Therapeutics, Inc	Apparatus and methods for administration of a nauseogenic compound from a drug delivery device
CN108211107B (zh) *	2018-03-01	2023-08-15	中南民族大学	一种针对穴位持续给药的压力可控式微泡贴及制备方法
USD933219S1 (en)	2018-07-13	2021-10-12	Intarcia Therapeutics, Inc.	Implant removal tool and assembly
IL282079B2 (en)	2018-10-11	2025-09-01	Intarcia Therapeutics Inc	Human amylin analog polypeptides and methods of use
RO134455A0 (ro) *	2019-11-27	2020-09-30	Ştefan-Sorin Aramă	Dispozitiv medical de temporizare
WO2025160155A1 (en)	2024-01-22	2025-07-31	The Broad Institute, Inc.	Epigenetic targeting of prion diseases

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US3732865A (en) *	1971-01-13	1973-05-15	Alza Corp	Osmotic dispenser
US3995632A (en) *	1973-05-04	1976-12-07	Alza Corporation	Osmotic dispenser
US3862042A (en) *	1974-02-27	1975-01-21	Becton Dickinson Co	Serum/plasma separator - piston with red-cell trapping surfaces
US4074715A (en) *	1976-11-01	1978-02-21	Becton, Dickinson And Company	Syringe plunger
US4619652A (en)	1982-12-23	1986-10-28	Alza Corporation	Dosage form for use in a body mounted pump
US4595583A (en) *	1984-03-19	1986-06-17	Alza Corporation	Delivery system controlled administration of beneficial agent to ruminants
US4624945A (en) *	1984-03-19	1986-11-25	Alza Corporation	Dispensing system with means for increasing delivery of beneficial agent from the system
US4838862A (en) *	1986-08-04	1989-06-13	Pharmetrix Corp.	Portable controlled release osmotic infusion device
US4874388A (en)	1987-06-25	1989-10-17	Alza Corporation	Multi-layer delivery system
US5062841A (en)	1988-08-12	1991-11-05	The Regents Of The University Of California	Implantable, self-regulating mechanochemical insulin pump
US4929233A (en) *	1988-08-26	1990-05-29	Alza Corporation	Implantable fluid imbibing pump with improved closure
US4969884A (en) *	1988-12-28	1990-11-13	Alza Corporation	Osmotically driven syringe
US5234424A (en)	1988-12-28	1993-08-10	Alza Corporation	Osmotically driven syringe
GB9027422D0 (en) *	1990-12-18	1991-02-06	Scras	Osmotically driven infusion device
US5236707A (en) *	1991-11-08	1993-08-17	Dallas Biotherapeutics, Inc.	Stabilization of human interferon
US5221278A (en) *	1992-03-12	1993-06-22	Alza Corporation	Osmotically driven delivery device with expandable orifice for pulsatile delivery effect
US5639477A (en)	1993-06-23	1997-06-17	Alza Corporation	Ruminal drug delivery device
PL189137B1 (pl) *	1996-02-02	2005-06-30	Alza Corp	Implantowane urządzenie do dostarczania substancji aktywnej
ZA981610B (en)	1997-03-24	1999-08-26	Alza Corp	Self adjustable exit port.
MY125849A (en) *	1997-07-25	2006-08-30	Alza Corp	Osmotic delivery system, osmotic delivery system semipermeable body assembly, and method for controlling delivery rate of beneficial agents from osmotic delivery systems
ES2217613T3 (es) *	1997-12-29	2004-11-01	Alza Corporation	Sistema de liberacion osmotica con mecanismo de retencion de tapon de membrana.
PT1051217E (pt) *	1997-12-31	2003-12-31	Alza Corp	Sistema de controlo osmotico de administracao de medicamento
ATE234603T1 (de) *	1998-12-31	2003-04-15	Alza Corp	Osmotisches verabreichungsystem mit raumsparenden kolben

1999
- 1999-12-21 AT AT99967575T patent/ATE234603T1/de active
- 1999-12-21 DK DK99967575T patent/DK1140014T3/da active
- 1999-12-21 PT PT99967575T patent/PT1140014E/pt unknown
- 1999-12-21 CA CA002356860A patent/CA2356860C/en not_active Expired - Fee Related
- 1999-12-21 EP EP99967575A patent/EP1140014B1/de not_active Expired - Lifetime
- 1999-12-21 WO PCT/US1999/030783 patent/WO2000040218A2/en not_active Ceased
- 1999-12-21 NZ NZ512671A patent/NZ512671A/en not_active IP Right Cessation
- 1999-12-21 DE DE69906132T patent/DE69906132T2/de not_active Expired - Lifetime
- 1999-12-21 HK HK02101884.5A patent/HK1040916B/en not_active IP Right Cessation
- 1999-12-21 ES ES99967575T patent/ES2196918T3/es not_active Expired - Lifetime
- 1999-12-21 JP JP2000591975A patent/JP4383674B2/ja not_active Expired - Fee Related
- 1999-12-21 AU AU23836/00A patent/AU771132B2/en not_active Ceased
- 1999-12-27 US US09/472,600 patent/US6544252B1/en not_active Expired - Lifetime
2003
- 2003-01-30 US US10/354,142 patent/US6872201B2/en not_active Expired - Lifetime
2004
- 2004-10-05 US US10/959,489 patent/US6997922B2/en not_active Expired - Lifetime
2006
- 2006-02-14 US US11/353,842 patent/US7235068B2/en not_active Expired - Fee Related
2007
- 2007-05-02 US US11/743,185 patent/US20070203476A1/en not_active Abandoned
2009
- 2009-04-08 JP JP2009094205A patent/JP2009183737A/ja not_active Withdrawn

Also Published As

Publication number	Publication date
WO2000040218A3 (en)	2000-11-09
ES2196918T3 (es)	2003-12-16
JP2002534164A (ja)	2002-10-15
EP1140014B1 (de)	2003-03-19
JP2009183737A (ja)	2009-08-20
US7235068B2 (en)	2007-06-26
US6872201B2 (en)	2005-03-29
HK1040916A1 (en)	2002-06-28
US20060129139A1 (en)	2006-06-15
AU2383600A (en)	2000-07-24
HK1040916B (en)	2003-10-03
NZ512671A (en)	2003-12-19
DK1140014T3 (da)	2003-07-14
DE69906132T2 (de)	2003-12-18
DE69906132D1 (de)	2003-04-24
US20050085797A1 (en)	2005-04-21
PT1140014E (pt)	2003-07-31
AU771132B2 (en)	2004-03-11
CA2356860C (en)	2006-11-07
US6544252B1 (en)	2003-04-08
US6997922B2 (en)	2006-02-14
CA2356860A1 (en)	2000-07-13
EP1140014A2 (de)	2001-10-10
JP4383674B2 (ja)	2009-12-16
US20030139732A1 (en)	2003-07-24
US20070203476A1 (en)	2007-08-30
WO2000040218A2 (en)	2000-07-13

Legal Events

Date

Code

Title

Description

2003-10-15

UEP

Publication of translation of european patent specification

Ref document number: 1140014

Country of ref document: EP

Publication	Publication Date	Title
ATE234603T1 (de)	2003-04-15	Osmotisches verabreichungsystem mit raumsparenden kolben
ATE376854T1 (de)	2007-11-15	Minimal nachgiebiger volumen-effizienter kolben für osmotische medikamentenabgabesysteme
ES2055445T3 (es)	1994-08-16	Proteinas de fusion que comprenden gm-csf e il-3.
ATE349700T1 (de)	2007-01-15	Übergangsmetallkomplex-haltige lumineszente proteinfarben
ATE71434T1 (de)	1992-01-15	Dosierpumpe.
DE59802964D1 (de)	2002-03-14	Kolbenmembranpumpe mit dichtungsloser kolben-zylindereinheit
KR970703752A (ko)	1997-08-09	액체 제제 내의 약물 투여용 제형(Dosage form for Administering Drug in Liquid Formulation)
DK0464140T3 (da)	1994-09-05	Aktivt adhæsionspeptid
HUP0104468A2 (hu)	2002-04-29	Elkülönített dimer fibroblaszt aktivációs alfa-protein és alkalmazása
ECSP024352A (es)	2003-03-31	Nueva composicion farmaceutica
PT1288223E (pt)	2005-03-31	Derivados de peptidos terapeuticos
CO4750807A1 (es)	1999-03-31	Solucion de interferon
DE58909266D1 (de)	1995-07-06	Pumpenaggregat.
ES2157523T3 (es)	2001-08-16	Solucion de dialisis peritoneal.
ATE92874T1 (de)	1993-08-15	Spender fuer pastoese produkte.
DK0707473T3 (da)	1999-01-04	Orale farmaceutiske præparater omfattende et protein eller et peptid, et antistof og polymerkugler
IT213756Z2 (it)	1990-02-16	Cappuccio di sigillo particolarmente per flaconi di antibiotici e di infusione e trasfusione.
PE20010596A1 (es)	2001-05-23	Tripsina libre de quimotripsina
DE3883055D1 (de)	1993-09-16	Enkastine: neue glycopeptide mit enkephalinase-hemmender wirkung, verfahren zu ihrer herstellung und ihre verwendung als pharmazeutische praeparate.
DE68913184D1 (de)	1994-03-24	Hochdruckpumpe mit hin -und wieder zurücklaufendem kolben.
FR2741808B1 (fr)	1998-01-16	Pompe de perfusion de liquides medicaux
CO4600680A1 (es)	1998-05-08	Procedimientos para la prevencion de la degradacion de la proteina c
ES2063360T3 (es)	1995-01-01	Analogos potentes de grf, estabilizados.
FI953871A0 (fi)	1995-08-16	Parannuksia injektioruiskujen mäntiin
MX9606042A (es)	1998-06-30	Fluido para dialisis que contiene peptidos obtenidos de caseina como agentes osmoticos e iones de bicarbonato como agentes reguladores de ph.